Home › Funds › Murchinson Ltd. › ORMP
Murchinson Ltd. position in ORMP
ORAMED PHARMACEUTICALS INC · Health Care
Murchinson Ltd. reported holding 2,142,118 shares of ORMP (ORAMED PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$10.0M, representing 1.91% of its reported portfolio and ranking #13 among its reported holdings. Murchinson Ltd. has disclosed ORMP holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Murchinson Ltd.'s ORMP position evolved
Murchinson Ltd. first disclosed a stake in ORMP in Q4 2023 at 1,050,000 shares (US$2.4M). The position peaked in Q3 2026 at 2,142,118 shares, worth US$10.0M. Across 12 filings, Murchinson Ltd. increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,142,118 shares valued at US$10.0M — an increase of 851,824 shares quarter over quarter.. Notable position changes include a 31% increase in Q1 2024 (shares fell 12% over the following quarter), a 66% increase in Q3 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.05M | $2.43M | New |
| Q1 2024 | 1.38M | $4.03M | Add |
| Q2 2024 | 1.70M | $4.37M | Add |
| Q3 2024 | 1.71M | $4.17M | Add |
| Q4 2024 | 1.75M | $4.24M | Add |
| Q1 2025 | 1.75M | $3.75M | Hold |
| Q2 2025 | 1.75M | $3.94M | Hold |
| Q3 2025 | 1.75M | $4.62M | Hold |
| Q4 2025 | 1.34M | $3.82M | Reduce |
| Q1 2026 | 1.32M | $4.47M | Reduce |
| Q2 2026 | 1.29M | $6.21M | Reduce |
| Q3 2026 | 2.14M | $10.00M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORMP and 13F data
ORMP (ORAMED PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORMP — the largest reported positions include Aquamarine Financial (Cayman) Ltd (US$12.4M), Gem Investment Advisors, LLC (US$9.3M), BML Capital Management, LLC (US$4.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORMP
- Aquamarine Financial (Cayman) Ltd 2.65M sh · $12.39M · Q3 2026
- Gem Investment Advisors, LLC 2.00M sh · $9.33M · Q3 2026
- BML Capital Management, LLC 884.39K sh · $4.13M · Q3 2026
More on Murchinson Ltd.
FAQ
How long has Murchinson Ltd. held ORMP?
Murchinson Ltd. has disclosed ORMP holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Murchinson Ltd.'s current position in ORMP?
As of Q3 2026, Murchinson Ltd. holds 2.14M shares of ORMP (ORAMED PHARMACEUTICALS INC), valued at $10.00M, representing 1.91% of its reported portfolio and ranking #13.
Has Murchinson Ltd. been buying or selling ORMP?
In the latest 13F filing (Q3 2026), Murchinson Ltd. increased its position in ORMP. The position peaked in Q3 2026 at 2.14M shares.
Which other funds hold ORMP?
Other major institutional holders of ORMP include Aquamarine Financial (Cayman) Ltd, Gem Investment Advisors, LLC, BML Capital Management, LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.